Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Founded in 1949 and headquartered in Piombino Dese, Italy, Stevanato is a leading global provider of drug containment and delivery solutions (think glass vials and syringes) to the pharmaceutical, biotechnology, and life sciences industries. The company remains...
— Adam J. Peck, CFA
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Stevanato Group S.p.A.
The strongest performer was pharmaceutical glass manufacturer Stevanto (STVN). The company’s products...
STVN provides drug containment and delivery solutions to pharmaceutical and biotechnology companies.
As businesses with unique and uncorrelated return drivers, Daikin and Corteva complement our existing Reversionary investments, such as pharmaceutical glass manufacturer Stevanato (STVN
More institutional theses from Riverwater Sustainable Value Strategy
Veeco Instruments ($VECO) manufactures specialized capital equipment essential for advanced semiconductor fabrication and microelectronics packaging. The fund maintains...
KBR ($KBR) provides scientific, engineering, and technology solutions across mission defense government contracting and proprietary industrial process licensing. The fund initiated...
Birkenstock ($BIRK) designs, manufactures, and markets premium anatomical footwear characterized by its signature contoured cork-latex footbed. The manager established...